keyword
https://read.qxmd.com/read/38584905/anticholinergic-toxidrome-due-to-thorn-apple-seed-ingestion-in-an-elderly-couple
#1
JOURNAL ARTICLE
Pepijn van Gastel, Jildou N Dijkstra, Mina A Jacob, Jeroen A Schouten, Bram Kok
INTRODUCTION: Sudden onset of reduced consciousness, psychomotor agitation and mydriasis are all indicative of an anticholinergic toxidrome. It is important to note that numerous drugs, as well as certain herbs and plants, possess anticholinergic properties. CASE DESCRIPTION: An 84-year-old female patient had sudden nocturnal onset of uncoordinated hand movements and altered mental status. Shortly after, the patient's 83-year-old husband developed symptoms of dysarthria, gait ataxia, vertigo, and delirium...
2024: European Journal of Case Reports in Internal Medicine
https://read.qxmd.com/read/38502289/an-evidence-based-update-on-anticholinergic-use-for-drug-induced-movement-disorders
#2
JOURNAL ARTICLE
Nora Vanegas-Arroyave, Stanley N Caroff, Leslie Citrome, Jovita Crasta, Roger S McIntyre, Jonathan M Meyer, Amita Patel, J Michael Smith, Khody Farahmand, Rachel Manahan, Leslie Lundt, Samantha A Cicero
Drug-induced movement disorders (DIMDs) are associated with use of dopamine receptor blocking agents (DRBAs), including antipsychotics. The most common forms are drug-induced parkinsonism (DIP), dystonia, akathisia, and tardive dyskinesia (TD). Although rare, neuroleptic malignant syndrome (NMS) is a potentially life-threatening consequence of DRBA exposure. Recommendations for anticholinergic use in patients with DIMDs were developed on the basis of a roundtable discussion with healthcare professionals with extensive expertise in DIMD management, along with a comprehensive literature review...
March 19, 2024: CNS Drugs
https://read.qxmd.com/read/38368318/prevalence-of-urinary-incontinence-and-associated-factors-in-nursing-homes-a-multicentre-cross-sectional-study
#3
MULTICENTER STUDY
Javier Jerez-Roig, Pau Farrés-Godayol, Meltem Yildirim, Anna Escribà-Salvans, Pau Moreno-Martin, Ester Goutan-Roura, Sandra Rierola-Fochs, Montse Romero-Mas, Joanne Booth, Dawn A Skelton, Maria Giné-Garriga, Eduard Minobes-Molina
BACKGROUND: Urinary incontinence (UI) is a common geriatric syndrome with high health and socio-economic impacts in nursing home (NH) residents. OBJECTIVES: To estimate the prevalence and types of UI and its associated factors in older people living in NHs in Central Catalonia (Spain). We also determined the proportion of residents who were receiving behavioural strategies to prevent/manage UI. DESIGN AND SETTING: Cross-sectional study in 5 NHs conducted from January to March 2020...
February 17, 2024: BMC Geriatrics
https://read.qxmd.com/read/37282618/eeg-changes-as-an-indication-of-central-nervous-system-involvement-following-cyclopentolate-1-eye-drops-a-randomized-placebo-controlled-pilot-study-in-a-pediatric-population
#4
JOURNAL ARTICLE
Helena Maria van Minderhout, Maurits Victor Joosse, Erica Surya Klaassen, Nicoline Elisabeth Schalij-Delfos
To compare EEG-patterns after instillation of cyclopentolate versus placebo eye drops. Prospective, randomized, placebo-controlled, and observational pilot study is presented. Ophthalmology outpatient clinic Dutch metropolitan hospital. Healthy 6- to 15-year-old volunteers with normal or low BMI requiring a cycloplegic refraction/retinoscopy. Randomized; 1 visit 2 drops cyclopentolate-1% and 1 visit 2 drops placebo (saline-0.9%). Single-blind: conducting researcher. Double blind: subjects, parents, clinical-neurophysiology staff, neurologist, and statistician...
June 6, 2023: Strabismus
https://read.qxmd.com/read/37251531/-central-anticholinergic-neuroleptic-malignant-and-serotonin-syndromes
#5
REVIEW
Tobias Hölle, Jan C Purrucker, Benedict Morath, Markus A Weigand, Felix C F Schmitt
Impaired consciousness is a frequent phenomenon after general anesthesia. In addition to the classical causes (e.g., overhang of sedatives), an impairment of consciousness can also be an adverse side effect of drugs. Many drugs used in anesthesia can trigger these symptoms. Alkaloids, such as atropine can trigger a central anticholinergic syndrome, opioids can promote the occurrence of serotonin syndrome and the administration of a neuroleptic can lead to neuroleptic malignant syndrome. These three syndromes are difficult to diagnose due to the individually very heterogeneous symptoms...
2023: Wiener Klinisches Magazin: Beilage Zur Wiener Klinischen Wochenschrift
https://read.qxmd.com/read/37160401/oral-anticholinergic-drugs-versus-placebo-or-no-treatment-for-managing-overactive-bladder-syndrome-in-adults
#6
REVIEW
Akvile Stoniute, Priya Madhuvrata, Madeleine Still, Evelyn Barron-Millar, Ghulam Nabi, Muhammad Imran Omar
BACKGROUND: Around 16% of adults have symptoms of overactive bladder (OAB; urgency with frequency and/or urge incontinence), with prevalence increasing with age. Anticholinergic drugs are commonly used to treat this condition. This is an update of a Cochrane Review first published in 2002 and last updated in 2006. OBJECTIVES: To assess the effects of anticholinergic drugs compared with placebo or no treatment for treating overactive bladder syndrome in adults. SEARCH METHODS: We searched the Cochrane Incontinence Specialised Register, which contains trials identified from the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE, MEDLINE In-Process, MEDLINE Epub Ahead of Print, ClinicalTrials...
May 9, 2023: Cochrane Database of Systematic Reviews
https://read.qxmd.com/read/37001688/a-novel-method-for-the-therapeutic-drug-monitoring-of-biperiden-in-plasma-by-gc-ms-using-salt-assisted-liquid-liquid-microextraction
#7
JOURNAL ARTICLE
Aykut Kul, Olcay Sagirli
Biperiden is an anticholinergic agent with central effects. It is used in Parkinson's syndromes and in the treatment of extrapyramidal symptoms that occur with the use of various agents (neuroleptics, antipsychotics). It causes anticholinergic syndrome in high doses. For this reason, therapeutic drug monitoring of biperiden is important. This study, it was aimed to develop a validated GC-MS method for the therapeutic monitoring of biperiden in human plasma. Biperiden and internal standard biperiden-d5 were extracted from plasma using the salt-assisted liquid-liquid extraction method...
March 29, 2023: Clinica Chimica Acta; International Journal of Clinical Chemistry
https://read.qxmd.com/read/36799968/-central-anticholinergic-neuroleptic-malignant-and-serotonin-syndromes-important-differential-diagnoses-in-postoperative-impairment-of-consciousness
#8
REVIEW
Tobias Hölle, Jan C Purrucker, Benedict Morath, Markus A Weigand, Felix C F Schmitt
Impaired consciousness is a frequent phenomenon after general anesthesia. In addition to the classical causes (e.g., overhang of sedatives), an impairment of consciousness can also be an adverse side effect of drugs. Many drugs used in anesthesia can trigger these symptoms. Alkaloids, such as atropine can trigger a central anticholinergic syndrome, opioids can promote the occurrence of serotonin syndrome and the administration of a neuroleptic can lead to neuroleptic malignant syndrome. These three syndromes are difficult to diagnose due to the individually very heterogeneous symptoms...
February 17, 2023: Anaesthesiologie
https://read.qxmd.com/read/36379687/central-anticholinergic-syndrome-from-hyoscine-hydrobromide-in-an-unresponsive-patient
#9
JOURNAL ARTICLE
David Murphy, Dympna Waldron, Grace Kennedy, Jack Molony
Terminal agitation is common and causes severe distress for patients and loved ones. Careful assessment is of paramount importance in identifying a cause. PA patient with gastric adenocarcinoma who was admitted with adverse effects post-chemotherapy deteriorated acutely with a presumed intracerebral event. Secretions were an issue and hyoscine hydrobromide was commenced. Within twenty-four hours, the patient became acutely agitated and did not respond to standard treatment.After careful clinical examination out-ruling other causes, toxic psychosis secondary to hyoscine hydrobromide was felt to be most likely...
November 15, 2022: BMJ Supportive & Palliative Care
https://read.qxmd.com/read/36347056/croi-2022-neurologic-complications-of-hiv-1-sars-cov-2-and-other-pathogens
#10
RANDOMIZED CONTROLLED TRIAL
Albert M Anderson, Scott L Letendre, Beau M Ances
The 2022 Conference on Retroviruses and Opportunistic Infections featured new and important findings about the neurologic complications of HIV-1, COVID-19, and other infections. Long-term analyses identified that cognitive decline over time, phenotypic aging, and stroke are associated with various comorbidities in people with HIV. Neuroimaging studies showed greater neuroinflammation, white matter damage, demyelination, and overall brain aging in people with chronic HIV infection. Childhood trauma and exposure to environmental pollutants contribute to these neuroimaging findings...
2022: Topics in Antiviral Medicine
https://read.qxmd.com/read/35579108/central-anticholinergic-syndrome-secondary-to-atropine-eye-drops-a-case-study
#11
Mickael Soletchnik, Geoffroy Rousseau, Lola Gonzalez, Saïd Laribi
Atropine eye drops are frequently used in the treatment of keratitis and during ophthalmic surgery. We described a rare complication of central anticholinergic syndrome secondary to atropine eye drops.
February 2023: British Journal of Clinical Pharmacology
https://read.qxmd.com/read/34998418/glycopyrrolate-for-drooling-in-children-with-medical-complexity-under-three-years-of-age
#12
JOURNAL ARTICLE
Eleonora Lovardi, Maria Antonietta De Ioris, Donatella Lettori, Caterina Geremia, Susanna Staccioli, Gessica Della Bella, Raffaella Scrocca, Alessia Scarselli, Marcella Aversa, Francesco De Peppo, Andrea Campana, Enrico Castelli
BACKGROUND: The aim of the study is to determine that Glycopirrolate is safe and effective in decreasing drooling in children with medical complexity under 3 years of age. Medical treatment is based on anticholinergic drugs as transdermal scopolamine, benzotropine and GLY. GLY (Glycopyrronium bromide) is a synthetic quaternary ammonium anticholinergic agent with poor blood-brain barrier penetration and consequently has limited central effects. Actually, the oral GLY formulation was approved by the United States Food and Drug Administration (FDA) to treat drooling in children aged 3-16 years...
January 8, 2022: Italian Journal of Pediatrics
https://read.qxmd.com/read/34876278/-anticholinergic-scales-use-in-psychiatry-and-update-of-the-anticholinergic-impregnation-scale
#13
REVIEW
H Javelot, G Meyer, G Becker, G Post, V Runge, P Pospieszynski, T Schneiderlin, S Armand-Branger, B Michel, L Weiner, C G F Faria, D Drapier, E Fakra, P Fossati, E Haffen, A Yrondi, C Hingray
Anticholinergic properties are well known to prescribers, notably in mental health, as a therapeutic strategy for i.e. extrapyramidal syndrome but also as a source of numerous adverse side effects. Herein, we propose a narrative literature review describing: (i) cholinergic pharmacology and anticholinergic properties; (ii) the importance of anticholinergic therapeutic properties in psychiatry; (iii) the existing anticholinergic drug scales and their usage limitations in Psychiatry and; last (iv) an update to the anticholinergic drug impregnation scale, designed for the French psychiatry practice...
June 2022: L'Encéphale
https://read.qxmd.com/read/34474941/unintentional-cetirizine-overdose-causing-anticholinergic-syndrome
#14
JOURNAL ARTICLE
Abagayle Renko, Teena Cortese, Paul Karagiannis, Matthew Salzman
The incidence of anticholinergic syndrome due to second generation antihistamines is infrequently reported. Largely due to their decreased affinity for central nervous system (CNS) receptors, second generation antihistamines are rarely associated with anticholinergic symptoms, though toxicity is still possible particularly when taken in excess. We report a case of a six year old boy who presented with agitation, hallucinations, fixed and dilated pupils, tachycardia, and hyperthermia consistent with anticholinergic toxicity several hours after accidental overdose of a second generation antihistamine, cetirizine...
February 2022: American Journal of Emergency Medicine
https://read.qxmd.com/read/34102130/the-use-of-physostigmine-in-the-diagnosis-and-treatment-of-anticholinergic-toxicity-after-olanzapine-overdose-literature-review-and-case-report
#15
REVIEW
Wilmarie Cidre Serrano, Jose Maldonado
BACKGROUND: Second-generation antipsychotic agents are commonly used by clinicians for the treatment of various psychiatric and medical conditions. Despite their presumed safety, an overdose with olanzapine may lead to the development of anticholinergic toxicity. The anticholinergic toxidrome is characterized by both central and peripheral physical findings. Central anticholinergic syndrome, a term used to describe the symptoms that arise from reduced cholinergic activity in the central nervous system, is characterized primarily by signs and symptoms consistent with hyperactive delirium...
May 2021: Journal of the Academy of Consultation—Liaison Psychiatry
https://read.qxmd.com/read/33993133/antispasmodics-for-chronic-abdominal-pain-analysis-of-north-american-treatment-options
#16
REVIEW
Darren M Brenner, Brian E Lacy
Chronic abdominal pain is a common gastrointestinal (GI) symptom that characterizes many functional GI disorders/disorders of gut-brain interaction, including irritable bowel syndrome, functional dyspepsia, and centrally mediated abdominal pain syndrome. The symptoms of abdominal pain in these highly prevalent disorders are often treated with antispasmodic agents. Antispasmodic treatment includes a broad range of therapeutic classes with different mechanisms of action, including anticholinergic/antimuscarinic agents (inhibition of GI smooth muscle contraction), calcium channel inhibitors (inhibition of calcium transport into GI smooth muscle), and direct smooth muscle relaxants (inhibition of sodium and calcium transport)...
August 1, 2021: American Journal of Gastroenterology
https://read.qxmd.com/read/33497502/bilateral-pallidal-stimulation-in-a-family-with-myoclonus-dystonia-syndrome-due-to-a-mutation-in-the-sarcoglycan-gene
#17
Michał Sobstyl, Angelika Stapińska-Syniec, Jacek Zaremba, Marta Jurek, Anna Kupryjaniuk, Marcin Rylski
OBJECTIVES: The study aimed to present a family with myoclonus dystonia (M-D) syndrome due to a mutation in the epsilon sarcoglycan gene (SGCE). Three members of the family suffered from treatment-refractory severe myoclonic jerks of the neck, trunk, and upper extremities. The mild dystonic symptoms recognized as cervical dystonia or truncal dystonia affected all individuals. The efficacy of pharmacotherapy, including anticholinergic, dopaminergic, and serotoninergic drugs, has failed...
January 26, 2021: Neuromodulation: Journal of the International Neuromodulation Society
https://read.qxmd.com/read/33376193/acute-onset-psychosis-with-complex-neurobehavioural-symptomatology-following-the-intramuscular-injection-of-hyoscine-butylbromide-a-case-report-with-an-overview-of-the-literature
#18
JOURNAL ARTICLE
Necati Serkut Bulut, Zeynep Beyza Arpacıoğlu
Different compounds of hyoscine (scopolamine) are widely used for the treatment of a variety of conditions, ranging from motion sickness to colic spasms and smoking cessation. In some rare conditions, the administration of scopolamine may lead to severe idiosyncratic reactions, including central anticholinergic intoxication syndrome. Here, we present a young female patient who progressively developed a series of complex neuropsychiatric symptoms including ataxia, slurred and rambling speech, stereotypic movements, vivid visual and auditory hallucinations, and self-mutilative behaviours in the days following the injection of hyoscine butylbromide in the emergency room to treat her menstrual cramps...
September 2022: European Journal of Hospital Pharmacy. Science and Practice
https://read.qxmd.com/read/32921995/cognitive-effects-of-anticholinergic-load-in-women-with-overactive-bladder
#19
REVIEW
George Araklitis, Dudley Robinson, Linda Cardozo
Overactive bladder syndrome (OAB) is defined as urinary urgency, usually accompanied by frequency and nocturia, with or without urgency incontinence, in the absence of urinary tract infection or other obvious pathology. The mainstay of treatment of OAB is anticholinergic/antimuscarinic medication. These drugs block muscarinic receptors throughout the body, not only the bladder, including in the brain, which may lead to cognitive side effects. Anticholinergic load or burden is the cumulative effect of taking drugs that are capable of producing anticholinergic adverse effects...
2020: Clinical Interventions in Aging
https://read.qxmd.com/read/32405660/is-imidafenacin-an-alternative-to-current-antimuscarinic-drugs-for-patients-with-overactive-bladder-syndrome
#20
REVIEW
Jia-Pei Wu, Liao Peng, Xiao Zeng, Hao Li, Hong Shen, De-Yi Luo
PURPOSE: Previous studies have included a limited number of randomized controlled trials (RCTs) and compared limited parameters after treatment with imidafenacin and other anticholinergic drugs (ADs) for overactive bladder syndrome (OAB), and controversy about the superiority of these ADs still remains. We aim to update the evidence and provide better clinical guidance. METHODS: A systematic search of PubMed, Embase, ClinicalTrial.gov and Cochrane Library Central Register of Controlled Trials was conducted from January 2007 to April 2019...
May 14, 2020: International Urogynecology Journal
keyword
keyword
74596
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.